India’s first indigenous mRNA vaccine candidate receives approval to initiate Phase 1 and 2 human clinical trials

India’s first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase one and two human clinical trials. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, Pune and supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the …

India’s first indigenous mRNA vaccine candidate receives approval to initiate Phase 1 and 2 human clinical trials Read More »